Fate Therapeutics, Inc. Share Price
NASDAQ: FATE | Small CapFate Therapeutics, Inc. Stock Performance
Open $2.51 | Prev. Close $2.71 | Circuit Range N/A |
Day Range $2.48 - $2.60 | Year Range $0.94 - $3.23 | Volume 69,609 |
Average Traded $2.55 |
Fate Therapeutics, Inc. Share Price Today
As of 16 August 2026, Fate Therapeutics, Inc.'s share price is $2.56. The stock opened at $2.51, compared to its previous close of $2.71. During today's trading session, Fate Therapeutics, Inc.'s share price traded between $2.48 and $2.60, with an average price of $2.54. Over the past 52 weeks, the stock has recorded a high of $3.23 and a low of $0.94. In terms of performance, Fate Therapeutics, Inc.'s share price has risen by 72.97% over the last six months and is up 146.15% on a year-on-year basis.
Fate Therapeutics, Inc. Share Price Chart
Fate Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $304.10M | PE Ratio (TTM) -2.23 | Dividend Yield N/A |
EPS (TTM) $-1.15 | Revenue (TTM) $6.65M | Return On Equity (TTM) -65.79% |
Profit Margin -2051.08% | Debt to Equity 0.17 | Quarterly Earnings Growth YoY 32.36% |
Fate Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Fate Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Fate Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.39 | $2.56 | +4.92% |
Jul 2026 | $2.67 | $2.44 | -10.13% |
Jun 2026 | $2.69 | $2.71 | -4.40% |
May 2026 | $1.25 | $2.84 | +127.20% |
Apr 2026 | $1.23 | $1.25 | +3.73% |
Mar 2026 | $1.44 | $1.21 | -18.58% |
Feb 2026 | $1.17 | $1.48 | +24.37% |
Jan 2026 | $1.00 | $1.19 | +20.93% |
Dec 2025 | $1.09 | $0.98 | -13.30% |
Nov 2025 | $1.37 | $1.14 | -16.85% |
Oct 2025 | $1.25 | $1.36 | +8.33% |
Sep 2025 | $1.04 | $1.26 | +21.15% |
FATE Share Price FAQs
What is Fate Therapeutics, Inc. share price today?
What is the 52 week high and 52 week low of Fate Therapeutics, Inc. stock?
What is FATE's market capitalisation today?
What is FATE's net income for the last quarter?
What is the 5 year returns of FATE?
What is the high & low stock price of FATE today?
Can I buy FATE shares in India?